WAST NHS to equip its frontline ambulances with ZOLL E Series EMS monitor/defibrillator

NewsGuard 100/100 Score

ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that the Welsh Ambulance Services (WAST) NHS is equipping its frontline ambulances with the ZOLL E Series® EMS monitor/defibrillator. Under the terms of the agreement, ZOLL plans to supply a total of 185 E Series units for distribution to the north, central and west, and southeast regions of the Welsh Service.

“And throughout our relationship with ZOLL, we've come to rely on them for excellent customer service.”

This contract, valued at $1.7 million (U.S.), is the largest order to date for the E Series in the United Kingdom. A ZOLL customer for 12 years, WAST is standardized on the Company's monitor/defibrillator products and updated to the E Series two years ago when it purchased 54 E Series units.

"From the outset, we've been impressed with the impact the full-featured E Series offers in improving outcomes from sudden cardiac arrest. The 12-lead STEMI option gives us the ability to simultaneously share information with the ED so they are prepared when the patient arrives," said a WAST spokesperson. "And throughout our relationship with ZOLL, we've come to rely on them for excellent customer service."

"ZOLL is pleased that the Welsh Ambulance Service Trust continues to use ZOLL as a partner in its mission to offer the best critical care for Welsh citizens. This upgrade of equipment demonstrates the value they place on advancing resuscitation care and we are pleased they continue to use ZOLL as a partner to help save more lives," said Jonathan A. Rennert, President of ZOLL.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals significant health benefits of golden berries in diabetic and obese rats